CYFRA (CA) 21-1 / SERUM

image not found

NABL Cap Accredited 

The CYFRA (CA) 21-1 Serum test measures a tumour marker commonly elevated in certain cancers, particularly lung cancer and other epithelial malignancies. Metropolis Healthcare performs this test using highly sensitive immunoassay techniques to ensure accurate detection and monitoring. It helps clinicians support diagnosis, assess treatment response, and monitor disease recurrence. When interpreted with imaging and clinical findings, it provides valuable insight into cancer management.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,605.00

Sample Type: SERUM

Fasting Not Required


Notes: C0212

Frequently Asked Questions (FAQ's):

What does the CYFRA 21-1 test include at Metropolis Healthcare?
It includes quantitative measurement of the CYFRA 21-1 tumour marker in serum.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced immunoassays and strict quality procedures.

Why is this tumour marker test important?
It assists in diagnosing and monitoring certain epithelial cancers.

Who should take this test at Metropolis Healthcare?
Patients suspected of lung cancer or under follow-up for epithelial malignancies.

Do I need special preparation before the test?
No special preparation is required; a serum sample is sufficient.

Can non-cancer conditions affect results?
Yes, inflammation or benign lung diseases may influence levels; Metropolis Healthcare interprets results carefully.

How soon can I get results from Metropolis Healthcare?
Results are usually available within the standard laboratory turnaround time.

How do clinicians use this test at Metropolis Healthcare?
It supports monitoring treatment response and detecting possible recurrence when used with other investigations.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab